Baixar PDF

Outros usuários também visualizaram estes artigos

HOW IMPORTANT IS THROMBOCYTOSIS FOR PROGNOSIS OF MDS WITH 3Q21Q26 SYNDROME? MS Couto; MML Melo; DP Borges; VS Oliveira; MA Viana; RTG Oliveira; TMCE Silva; RFP Filho; SMM Magalhães; RF Pinheiro;
Hematol Transfus Cell Ther. 2022;44 Supl 2:S202
ATM DNA METHYLATION ASSOCIATED WITH POOR PROGNOSIS AND LEUKEMIA TRANSFORMATION IN MYELODYSPLASTIC SYNDROME PATIENTS VS Oliveira; MC Braga; CS Monte; MA Viana; LR Sampaio; JVC Goes; GFA Pinheiro; NFA Minete; RF Pinheiro; SMM Magalhães;
Hematol Transfus Cell Ther. 2022;44 Supl 2:S207
INCREASED PROGRAMMED DEATH LIGAND-1 EXPRESSION LEADS TO WORSE CLINICAL FEATURES IN PATIENTS WITH MYELODYSPLASTIC SYNDROME LR Sampaio; VS Oliveira; MA Viana; BV Ferreira; MML Melo; TMCE Silva; RCO Ribeiro; RDB Dias; SMM Magalhães; RF Pinheiro;
Hematol Transfus Cell Ther. 2022;44 Supl 2:S201